This suggests that ILK may be involved in the migration of monocytes exposed to pc and IS across ECM barriers, a response that may underlie cardiovascular damage in CKD, which primarily relies on interactions among the endothelium, vascular cells, and monocyte-derived macrophages. This evidence concerns the gene ILK and chronic kidney disease.